Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/47539

Registo completo
Campo DCValorIdioma
dc.contributor.authorLopes, Susana P.por
dc.contributor.authorAzevedo, Nuno Filipepor
dc.contributor.authorPereira, Maria Olíviapor
dc.date.accessioned2017-11-20T10:00:24Z-
dc.date.available2017-11-20T10:00:24Z-
dc.date.issued2017-12-
dc.identifier.citationLopes, Susana P.; Azevedo, Nuno Filipe; Pereira, Maria Olívia, Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress. International Journal of Medical Microbiology, 307(8), 460-470, 2017por
dc.identifier.issn1618-0607por
dc.identifier.urihttps://hdl.handle.net/1822/47539-
dc.description.abstractCystic fibrosis (CF) infections are invariably biofilm-mediated and polymicrobial, being safe to assume that a myriad of factors affects the sociomicrobiology within the CF infection site and modulate the CF community dynamics, by shaping their social activities, overall functions, virulence, ultimately affecting disease outcome. This work aimed to assess changes in the dynamics (particularly on the microbial composition) of dual-/three-species biofilms involving CF-classical (Pseudomonas aeruginosa) and unusual species (Inquilinus limosus and Dolosigranulum pigrum), according to variable oxygen conditions and antibiotic exposure. Low fluctuations in biofilm compositions were observed across distinct oxygen environments, with dual-species biofilms exhibiting similar relative proportions and P. aeruginosa and/or D. pigrum populations dominating three-species consortia. Once exposed to antibiotics, biofilms displayed high resistance profiles, and microbial compositions, distributions, and microbial interactions significantly challenged. The antibiotic/oxygen environment supported such fluctuations, which enhanced for three-species communities. In conclusion, antibiotic therapy hugely disturbed CF communities dynamics, inducing significant compositional changes on multispecies consortia. Clearly, multiple perturbations may disturb this dynamic, giving rise to various microbiological scenarios in vivo, and affecting disease phenotype. Therefore, an appreciation of the ecological/evolutionary nature within CF communities will be useful for the optimal use of current therapies and for newer breakthroughs on CF antibiotherapy.por
dc.description.sponsorshipThis study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/ BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER006684). The authors also acknowledge the financial support provided by FCT through the projects: PTDC/SAU-ESA/646091/2006/ FCOMP01-0124-FEDER-007480FCT; strategic project PEst-OE/EQB/LA0023/2013; “BioHealth – Biotechnology and Bioengineering approaches to improve health quality”, Ref. NORTE-07-0124-FEDER-000027, cofunded by the Programa Operacional Regional do Norte (ON.2–O Novo Norte), QREN, FEDER; RECI/BBB-EBI/0179/2012 – Consolidating Research Expertise and Resources on Cellular and Molecular Biotechnology at CEB/IBB, FCOMP-01-0124-FEDER-027462, FEDER; and the DNA mimics project PIC/IC/82815/2007. The FCT BPD fellowship of Susana P. Lopes SFRH/BPD/95616/2013 and the support of the COST-Action TD1004:Theragnostics for imaging and therapy is also acknowledged.por
dc.language.isoengpor
dc.publisherElsevier 1por
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147337/PTpor
dc.relationPTDC/SAU-ESA/646091/2006por
dc.relationinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/132966/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876-PPCDTI/126270/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/COMPETE/126270/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/5646-ICCMS/82815/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F95616%2F2013/PTpor
dc.rightsopenAccesspor
dc.subjectantibiotic therapypor
dc.subjectcystic fibrosispor
dc.subjectinterspecies interactionspor
dc.subjectpolymicrobial biofilmspor
dc.subjectPseudomonas aeruginosapor
dc.titleDeveloping a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stresspor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://www.journals.elsevier.com/international-journal-of-medical-microbiology/por
dc.commentsCEB46989por
oaire.citationStartPage460por
oaire.citationEndPage470por
oaire.citationIssue8por
oaire.citationConferencePlaceNetherlands-
oaire.citationVolume307por
dc.date.updated2017-11-18T16:41:42Z-
dc.identifier.eissn1438-4221por
dc.identifier.doi10.1016/j.ijmm.2017.09.018por
dc.identifier.pmid29033313por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technologypor
sdum.journalInternational Journal of Medical Microbiologypor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_46989_1.pdf1,44 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID